Table 4 Comparison of median treatment incidences (TI) for different antimicrobial classes and administration route before and after intervention (n = 67)
Parameter | Median before intervention (Q25; Q75) | Median after intervention (Q25; Q75) | p-valuea | Difference in percentage (%) |
|---|---|---|---|---|
TI 3rd generation cephalosporins | 0 (0.0; 10.3) | 0 (0.0; 1.1) | 0.09 | 0 |
TI Aminoglycosides | 0 (0.0; 0.7) | 0 (0.0; 0.6) | 0.24 | 0 |
TI Aminopenicillins | 139.6 (20.2; 414.0) | 136.0 (15.9; 350.3) | 0.19 | −3 |
TI Benzylpenicillin | 0 (0.0; 14.5) | 0 (0.0; 17.8) | 0.62 | 0 |
TI Benzylpenicillin-combinations | 0 (0.0; 14.5) | 0 (0.0; 5.6) | 0.01 | 0 |
TI Florfenicols | 0 (0.0; 0.0) | 0 (0.0; 0.5) | 0.81 | 0 |
TI Fluorquinolones | 9.5 (3.7; 27.3) | 7.6 (1.0; 28.0) | 0.15 | −20 |
TI Macrolides | 12.6 (0.3; 208.7) | 12.4 (0.0; 203.4) | 0.84 | −1 |
TI Macrolide-combinations | 0 (0.0; 0.6) | 0 (0.0; 0.2) | 0.12 | 0 |
TI Pleuromutilins | 0 (0.0; 0.0) | 0 (0.0; 0.0) | 0.18 | 0 |
TI Polymyxins | 106.8 (1.1; 467.8) | 33.2 (0.0; 155.4) | < 0.001 | −69 |
TI Tetracyclines | 50.7 (0.2; 255.1) | 26.1 (0.1; 107.1) | 0.01 | −49 |
TI Trimethoprim-Sulfonamides | 2.3 (0.0; 30.4) | 0.1 (0.0; 22.8) | 0.60 | − 96 |
Administration route parenteral | 300.0 (141.2; 493.4) | 192.5 (111.7; 406.3) | 0.01 | −36 |
Administration route feed/water | 601.3 (69.8; 1295.7) | 322.0 (77.4; 632.2) | < 0.001 | −46 |